Distearoylphosphatidylcholine

Last updated
Distearoylphosphatidylcholine
Distearoylphosphatidylcholine-line.png
Names
Systematic IUPAC name
(2R)-2,3-Bis(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
Other names
1,2-distearoyl-sn-glycero-3-phosphocholine, DSPC, 18:0 PC
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.011.309 OOjs UI icon edit-ltr-progressive.svg
EC Number
  • 212-440-2
PubChem CID
UNII
  • InChI=1S/C44H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h42H,6-41H2,1-5H3/t42-/m1/s1
    Key: NRJAVPSFFCBXDT-HUESYALOSA-N
  • O=C(OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C)CCCCCCCCCCCCCCCCC
Properties
C44H88NO8P
Molar mass 790.161 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Distearoylphosphatidylcholine is a phosphatidylcholine, a kind of phospholipid. It is a natural constituent of cell membranes, eg. soybean phosphatidylcholines are mostly different 18-carbon phosphatidylcholines (including minority of saturated DSPC), and their hydrogenation results in 85% DSPC. [1] It can be used to prepare lipid nanoparticles which are used in mRNA vaccines, [2] [3] In particular, it forms part of the drug delivery system for the Moderna and Pfizer COVID-19 vaccines. [4] [5]


See also

Moderna COVID-19 vaccine nanoparticle ingredients
Others

References

  1. ↑ van Hoogevest P, Wendel A (2014). "The use of natural and synthetic phospholipids as pharmaceutical excipients". The European Journal of Lipid Science and Technology. 116 (9): 1088–1107. doi:10.1002/ejlt.201400219. PMC   4207189 . PMID   25400504.
  2. ↑ Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R (2009). "Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic". Critical Reviews in Therapeutic Drug Carrier Systems. 26 (6): 523–80. doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10. PMC   2885142 . PMID   20402623.
  3. ↑ Salvatori G, Luberto L, and Marra E (2020). "SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines". Journal of Translational Medicine. 18 (1) 222. doi: 10.1186/s12967-020-02392-y . PMC   7268185 . PMID   32493510.
  4. ↑ "Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). Centers for Disease Control and Prevention (CDC).
  5. ↑ "Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers". Food and Drug Administration (FDA). 29 June 2022. Archived from the original on December 12, 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.